Related references
Note: Only part of the references are listed.Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
Ivan Mercurio et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Non-viral COVID-19 vaccine delivery systems
Kyung Soo Park et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Principles and Challenges in anti-COVID-19 Vaccine Development
Zuzana Strizova et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2021)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang et al.
LANCET INFECTIOUS DISEASES (2021)
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
Sara E. Oliver et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
The Relevance of Bioinformatics Applications in the Discovery of Vaccine Candidates and Potential Drugs for COVID-19 Treatment
Onyeka S. Chukwudozie et al.
BIOINFORMATICS AND BIOLOGY INSIGHTS (2021)
Signals of Th2 immune response from COVID-19 patients requiring intensive care
Luca Roncati et al.
ANNALS OF HEMATOLOGY (2020)
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
Mihai G. Netea et al.
CELL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus
Md Asad Ullah et al.
IMMUNOBIOLOGY (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Jieliang Wang et al.
AAPS PHARMSCITECH (2020)
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
Sarah M. Bartsch et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Colin D. Funk et al.
FRONTIERS IN PHARMACOLOGY (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome
Stephen N. Crooke et al.
SCIENTIFIC REPORTS (2020)
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis
Onyeka S. Chukwudozie et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
Giulia Russo et al.
BMC BIOINFORMATICS (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Defining trained immunity and its role in health and disease
Mihai G. Netea et al.
NATURE REVIEWS IMMUNOLOGY (2020)
In silico clinical trials: concepts and early adoptions
Francesco Pappalardo et al.
BRIEFINGS IN BIOINFORMATICS (2019)
Immunoinformatics: In Silico Approaches and Computational Design of a Multi-epitope, Immunogenic Protein
Armina Alagheband Bahrami et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2019)
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Zhiqi Song et al.
VIRUSES-BASEL (2019)
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Eva Kaufmann et al.
CELL (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Viral-Induced Enhanced Disease Illness
Maria K. Smatti et al.
FRONTIERS IN MICROBIOLOGY (2018)
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Dimitrios Gouglas et al.
LANCET GLOBAL HEALTH (2018)
A computational model to predict the immune system activation by citrus-derived vaccine adjuvants
Francesco Pappalardo et al.
BIOINFORMATICS (2016)
Cancer immunoprevention
Olivera J. Finn et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Computational modelling approaches to vaccinology
Francesco Pappalardo et al.
PHARMACOLOGICAL RESEARCH (2015)
Vaccines for the 21st century
Isabel Delany et al.
EMBO MOLECULAR MEDICINE (2014)
Bridging experiments, models and simulations: an integrative approach to validation in computational cardiac electrophysiology
Annamaria Carusi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLoS One (2012)
In Silico Augmentation of the Drug Development Pipeline: Examples From the Study of Acute Inflammation
Gary An et al.
DRUG DEVELOPMENT RESEARCH (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Vaccine protocols optimization: In silico experiences
Francesco Pappalardo et al.
BIOTECHNOLOGY ADVANCES (2010)
Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview
Esther M. Lafuente et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Share Paper
